XML 36 R18.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Accounting Policies [Abstract]    
Schedule of Useful Lives for Property Plant Equipment

 

Furniture   5 years
Computers and equipment   5 years
Research Equipment   10 years

 

Furniture 5 years
Computers and equipment 5 years
Research Equipment 10 years
Schedule of Fair Value by Liabilities on Balance Sheet

At December 31, 2021, the Company identified the following liabilities that are required to be presented on the balance sheet at fair value:

 

December 31, 2021  Level 1   Level 2   Level 3   Total 
Liabilities                    
Warrant Liabilities  $-   $-   $94,025   $94,025 

At December 31, 2021, the Company identified the following liabilities that are required to be presented on the balance sheet at fair value:

 

Description  Level 1   Level 2   Level 3 
Warrant Liability  $-   $-   $94,025 
                           

 

At December 31, 2020, the Company identified the following liabilities that are required to be presented on the balance sheet at fair value:

 

Description  Level 1   Level 2   Level 3 
Warrant Liability  $-   $-   $673,171 
                              
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share

For the nine months ended September 30, 2022 and year ended December 31, 2021, the following common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive.

 

   September 30,   December 31, 
   2022   2021 
Series A preferred stock   -    97,062 
Warrants   20,000    48,532 
Anti dilutive securities excluded from computation of earnings per share   20,000    145,594 

For the years ended December 31, 2021, and 2020, the following common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive.

 

   December 31,   December 31, 
   2021   2020 
Series A preferred stock   97,062    97,062 
Warrants   48,532    48,532 
Total   145,594    145,594